As filed with the Securities and Exchange Commission on March 30, 2023
Registration No. 333-
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Adverum Biotechnologies, Inc.
(Exact name of Registrant as specified in its charter)
| | |
Delaware | | 20-5258327 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
| | |
100 Cardinal Way Redwood City, California | | 94063 |
(Address of registrant’s principal executive offices) | | Zip code |
2014 Equity Incentive Award Plan, as amended and restated
(Full title of the plans)
Peter Soparkar
Chief Operating Officer
Adverum Biotechnologies, Inc.
100 Cardinal Way
Redwood City, California 94063
(650) 656-9323
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Kenneth Guernsey
CooleyLLP
3 Embarcadero Center, 20th Floor
San Francisco, CA 94111-4004
(415) 693-2000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐